HLS Therapeutics Inc.

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, MKGAF has a market cap of 67.2B. Regarding current trading prices, HLTRF is priced at $3.36, while MKGAF trades at $149.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas MKGAF's P/E ratio is 19.19. In terms of profitability, HLTRF's ROE is -0.21%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, HLTRF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check MKGAF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, MKKGY has a market cap of 64.8B. Regarding current trading prices, HLTRF is priced at $3.36, while MKKGY trades at $29.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas MKKGY's P/E ratio is 18.52. In terms of profitability, HLTRF's ROE is -0.21%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, HLTRF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check MKKGY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, IPSEY has a market cap of 61B. Regarding current trading prices, HLTRF is priced at $3.36, while IPSEY trades at $46.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas IPSEY's P/E ratio is 29.02. In terms of profitability, HLTRF's ROE is -0.21%, compared to IPSEY's ROE of +0.11%. Regarding short-term risk, HLTRF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check IPSEY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TKPHF has a market cap of 58.4B. Regarding current trading prices, HLTRF is priced at $3.36, while TKPHF trades at $37.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TKPHF's P/E ratio is 80.43. In terms of profitability, HLTRF's ROE is -0.21%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, HLTRF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check TKPHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HLNCF has a market cap of 49.3B. Regarding current trading prices, HLTRF is priced at $3.36, while HLNCF trades at $5.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HLNCF's P/E ratio is 24.04. In terms of profitability, HLTRF's ROE is -0.21%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, HLTRF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HLNCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SDZNY has a market cap of 36.8B. Regarding current trading prices, HLTRF is priced at $3.36, while SDZNY trades at $85.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SDZNY's P/E ratio is 164.50. In terms of profitability, HLTRF's ROE is -0.21%, compared to SDZNY's ROE of +0.02%. Regarding short-term risk, HLTRF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SDZNY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, HLTRF is priced at $3.36, while TEVJF trades at $28.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, HLTRF's ROE is -0.21%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, HLTRF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check TEVJF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SGIOF has a market cap of 22.1B. Regarding current trading prices, HLTRF is priced at $3.36, while SGIOF trades at $25.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SGIOF's P/E ratio is 20.27. In terms of profitability, HLTRF's ROE is -0.21%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, HLTRF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SGIOF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SGIOY has a market cap of 20B. Regarding current trading prices, HLTRF is priced at $3.36, while SGIOY trades at $11.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SGIOY's P/E ratio is 17.80. In terms of profitability, HLTRF's ROE is -0.21%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, HLTRF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SGIOY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, HLTRF is priced at $3.36, while TAIPY trades at $14.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, HLTRF's ROE is -0.21%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, HLTRF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check TAIPY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, HLTRF is priced at $3.36, while ESALY trades at $61.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HLTRF's ROE is -0.21%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HLTRF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check ESALY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, BIOVF has a market cap of 12.8B. Regarding current trading prices, HLTRF is priced at $3.36, while BIOVF trades at $37.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas BIOVF's P/E ratio is 246.67. In terms of profitability, HLTRF's ROE is -0.21%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, HLTRF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check BIOVF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ESAIY has a market cap of 9.4B. Regarding current trading prices, HLTRF is priced at $3.36, while ESAIY trades at $8.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ESAIY's P/E ratio is 28.31. In terms of profitability, HLTRF's ROE is -0.21%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, HLTRF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check ESAIY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, HLTRF is priced at $3.36, while IPSEF trades at $113.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, HLTRF's ROE is -0.21%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, HLTRF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check IPSEF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, HLTRF is priced at $3.36, while ESALF trades at $33.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ESALF's P/E ratio is 28.70. In terms of profitability, HLTRF's ROE is -0.21%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, HLTRF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check ESALF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SMDPY has a market cap of 7.2B. Regarding current trading prices, HLTRF is priced at $3.36, while SMDPY trades at $24.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SMDPY's P/E ratio is 4.32. In terms of profitability, HLTRF's ROE is -0.21%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, HLTRF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SMDPY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, HLTRF is priced at $3.36, while SFOSF trades at $2.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SFOSF's P/E ratio is 14.50. In terms of profitability, HLTRF's ROE is -0.21%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, HLTRF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SFOSF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, DNPUF has a market cap of 6.5B. Regarding current trading prices, HLTRF is priced at $3.36, while DNPUF trades at $16.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas DNPUF's P/E ratio is 6.37. In terms of profitability, HLTRF's ROE is -0.21%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, HLTRF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check DNPUF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, HLTRF is priced at $3.36, while LVZPF trades at $5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, HLTRF's ROE is -0.21%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, HLTRF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check LVZPF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, HLTRF is priced at $3.36, while GZPHF trades at $2.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, HLTRF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check GZPHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, HLTRF is priced at $3.36, while HLUBF trades at $5.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HLUBF's P/E ratio is 11.43. In terms of profitability, HLTRF's ROE is -0.21%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, HLTRF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HLUBF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, HLTRF is priced at $3.36, while HLBBF trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HLBBF's P/E ratio is 11.96. In terms of profitability, HLTRF's ROE is -0.21%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, HLTRF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HLBBF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HKMPY has a market cap of 4.8B. Regarding current trading prices, HLTRF is priced at $3.36, while HKMPY trades at $43.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HKMPY's P/E ratio is 13.10. In terms of profitability, HLTRF's ROE is -0.21%, compared to HKMPY's ROE of +0.15%. Regarding short-term risk, HLTRF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HKMPY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HKMPF has a market cap of 4.8B. Regarding current trading prices, HLTRF is priced at $3.36, while HKMPF trades at $21.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HKMPF's P/E ratio is 13.03. In terms of profitability, HLTRF's ROE is -0.21%, compared to HKMPF's ROE of +0.15%. Regarding short-term risk, HLTRF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HKMPF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SGFEF has a market cap of 4.6B. Regarding current trading prices, HLTRF is priced at $3.36, while SGFEF trades at $104.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SGFEF's P/E ratio is 23.51. In terms of profitability, HLTRF's ROE is -0.21%, compared to SGFEF's ROE of +0.15%. Regarding short-term risk, HLTRF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check SGFEF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ULIHF has a market cap of 3.7B. Regarding current trading prices, HLTRF is priced at $3.36, while ULIHF trades at $1.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ULIHF's P/E ratio is 7.81. In terms of profitability, HLTRF's ROE is -0.21%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, HLTRF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check ULIHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, HLTRF is priced at $3.36, while APNHF trades at $8.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas APNHF's P/E ratio is -54.67. In terms of profitability, HLTRF's ROE is -0.21%, compared to APNHF's ROE of -0.01%. Regarding short-term risk, HLTRF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check APNHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, APNHY has a market cap of 3.5B. Regarding current trading prices, HLTRF is priced at $3.36, while APNHY trades at $7.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas APNHY's P/E ratio is -52.13. In terms of profitability, HLTRF's ROE is -0.21%, compared to APNHY's ROE of -0.01%. Regarding short-term risk, HLTRF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check APNHY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, HLTRF is priced at $3.36, while LBTSF trades at $15.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas LBTSF's P/E ratio is 66.74. In terms of profitability, HLTRF's ROE is -0.21%, compared to LBTSF's ROE of +0.03%. Regarding short-term risk, HLTRF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check LBTSF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, HLTRF is priced at $3.36, while CHSYF trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, HLTRF's ROE is -0.21%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, HLTRF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CHSYF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, HLTRF is priced at $3.36, while INVVY trades at $21.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HLTRF's ROE is -0.21%, compared to INVVY's ROE of -0.60%. Regarding short-term risk, HLTRF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check INVVY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, HLTRF is priced at $3.36, while IZQVF trades at $20.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HLTRF's ROE is -0.21%, compared to IZQVF's ROE of -0.60%. Regarding short-term risk, HLTRF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check IZQVF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, HLTRF is priced at $3.36, while HYPMY trades at $4.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HYPMY's P/E ratio is 17.60. In terms of profitability, HLTRF's ROE is -0.21%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, HLTRF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HYPMY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HMDCF has a market cap of 2.6B. Regarding current trading prices, HLTRF is priced at $3.36, while HMDCF trades at $3.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HMDCF's P/E ratio is 5.70. In terms of profitability, HLTRF's ROE is -0.21%, compared to HMDCF's ROE of +0.47%. Regarding short-term risk, HLTRF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check HMDCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, HLTRF is priced at $3.36, while NPPNY trades at $8.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas NPPNY's P/E ratio is 10.78. In terms of profitability, HLTRF's ROE is -0.21%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, HLTRF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check NPPNY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, HLTRF is priced at $3.36, while DMPHF trades at $39.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, HLTRF's ROE is -0.21%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, HLTRF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check DMPHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, HLTRF is priced at $3.36, while NPNKF trades at $30.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas NPNKF's P/E ratio is 9.84. In terms of profitability, HLTRF's ROE is -0.21%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, HLTRF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check NPNKF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, HLTRF is priced at $3.36, while HTSUF trades at $29.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, HLTRF's ROE is -0.21%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, HLTRF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HTSUF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, HLTRF is priced at $3.36, while ARSUF trades at $27.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ARSUF's P/E ratio is 19.42. In terms of profitability, HLTRF's ROE is -0.21%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, HLTRF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check ARSUF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, HLTRF is priced at $3.36, while DUTV trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas DUTV's P/E ratio is N/A. In terms of profitability, HLTRF's ROE is -0.21%, compared to DUTV's ROE of -0.05%. Regarding short-term risk, HLTRF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check DUTV's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, HLTRF is priced at $3.36, while TSMRF trades at $23.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, HLTRF's ROE is -0.21%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, HLTRF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check TSMRF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CURLF has a market cap of 1.7B. Regarding current trading prices, HLTRF is priced at $3.36, while CURLF trades at $2.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CURLF's P/E ratio is -6.25. In terms of profitability, HLTRF's ROE is -0.21%, compared to CURLF's ROE of -0.31%. Regarding short-term risk, HLTRF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CURLF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, HLTRF is priced at $3.36, while MITPF trades at $23.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas MITPF's P/E ratio is -10.81. In terms of profitability, HLTRF's ROE is -0.21%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, HLTRF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check MITPF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SHPHF has a market cap of 1.6B. Regarding current trading prices, HLTRF is priced at $3.36, while SHPHF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SHPHF's P/E ratio is -5.67. In terms of profitability, HLTRF's ROE is -0.21%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, HLTRF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SHPHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, HLTRF is priced at $3.36, while KARBF trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HLTRF's ROE is -0.21%, compared to KARBF's ROE of N/A. Regarding short-term risk, HLTRF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check KARBF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, HLTRF is priced at $3.36, while GTBIF trades at $6.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas GTBIF's P/E ratio is 38.12. In terms of profitability, HLTRF's ROE is -0.21%, compared to GTBIF's ROE of +0.02%. Regarding short-term risk, HLTRF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check GTBIF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, EVOTF has a market cap of 1.4B. Regarding current trading prices, HLTRF is priced at $3.36, while EVOTF trades at $8.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas EVOTF's P/E ratio is -7.42. In terms of profitability, HLTRF's ROE is -0.21%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, HLTRF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check EVOTF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, HLTRF is priced at $3.36, while CHIZF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, HLTRF's ROE is -0.21%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, HLTRF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check CHIZF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, HLTRF is priced at $3.36, while SWGHF trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, HLTRF's ROE is -0.21%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, HLTRF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SWGHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, HLTRF is priced at $3.36, while CASBF trades at $3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CASBF's P/E ratio is -37.50. In terms of profitability, HLTRF's ROE is -0.21%, compared to CASBF's ROE of -0.03%. Regarding short-term risk, HLTRF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check CASBF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, HLTRF is priced at $3.36, while LJUIF trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, HLTRF's ROE is -0.21%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, HLTRF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check LJUIF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, HLTRF is priced at $3.36, while TCNNF trades at $6.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TCNNF's P/E ratio is -9.79. In terms of profitability, HLTRF's ROE is -0.21%, compared to TCNNF's ROE of -0.11%. Regarding short-term risk, HLTRF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check TCNNF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, HLTRF is priced at $3.36, while KSPHF trades at $26.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas KSPHF's P/E ratio is 12.04. In terms of profitability, HLTRF's ROE is -0.21%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, HLTRF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check KSPHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, HLTRF is priced at $3.36, while BIOGY trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, HLTRF's ROE is -0.21%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, HLTRF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check BIOGY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, GNMLF has a market cap of 1B. Regarding current trading prices, HLTRF is priced at $3.36, while GNMLF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas GNMLF's P/E ratio is 10.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to GNMLF's ROE of +0.13%. Regarding short-term risk, HLTRF is less volatile compared to GNMLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check GNMLF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, HLTRF is priced at $3.36, while KKPCF trades at $26.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, HLTRF's ROE is -0.21%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, HLTRF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check KKPCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, HLTRF is priced at $3.36, while TWAPF trades at $16.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, HLTRF's ROE is -0.21%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, HLTRF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check TWAPF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, HLTRF is priced at $3.36, while NIKA trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas NIKA's P/E ratio is N/A. In terms of profitability, HLTRF's ROE is -0.21%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, HLTRF is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check NIKA's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, HLTRF is priced at $3.36, while CSWYF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, HLTRF's ROE is -0.21%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, HLTRF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CSWYF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, HLTRF is priced at $3.36, while TRXPF trades at $24.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HLTRF's ROE is -0.21%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, HLTRF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check TRXPF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, HLTRF is priced at $3.36, while SHEZF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, HLTRF's ROE is -0.21%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, HLTRF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check SHEZF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, HLTRF is priced at $3.36, while YIHCF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, HLTRF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check YIHCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, HLTRF is priced at $3.36, while AIHLF trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, HLTRF's ROE is -0.21%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HLTRF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check AIHLF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, HLTRF is priced at $3.36, while TRSSF trades at $1.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HLTRF's ROE is -0.21%, compared to TRSSF's ROE of -0.85%. Regarding short-term risk, HLTRF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check TRSSF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, GLASF has a market cap of 588.6M. Regarding current trading prices, HLTRF is priced at $3.36, while GLASF trades at $7.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas GLASF's P/E ratio is -36.27. In terms of profitability, HLTRF's ROE is -0.21%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, HLTRF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check GLASF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, HLTRF is priced at $3.36, while PKBFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas PKBFF's P/E ratio is N/A. In terms of profitability, HLTRF's ROE is -0.21%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HLTRF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check PKBFF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, HLTRF is priced at $3.36, while CCHWF trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HLTRF's ROE is -0.21%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, HLTRF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CCHWF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, HLTRF is priced at $3.36, while BOIRF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, HLTRF's ROE is -0.21%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, HLTRF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check BOIRF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, HLTRF is priced at $3.36, while AGYTF trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, HLTRF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check AGYTF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, KHTRF has a market cap of 474.3M. Regarding current trading prices, HLTRF is priced at $3.36, while KHTRF trades at $4.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas KHTRF's P/E ratio is -157.42. In terms of profitability, HLTRF's ROE is -0.21%, compared to KHTRF's ROE of -0.00%. Regarding short-term risk, HLTRF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check KHTRF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, HLTRF is priced at $3.36, while PEXXF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HLTRF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check PEXXF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SWDCF has a market cap of 443.7M. Regarding current trading prices, HLTRF is priced at $3.36, while SWDCF trades at $2.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SWDCF's P/E ratio is 69.40. In terms of profitability, HLTRF's ROE is -0.21%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HLTRF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check SWDCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, HLTRF is priced at $3.36, while HUMDF trades at $0.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas HUMDF's P/E ratio is 2.74. In terms of profitability, HLTRF's ROE is -0.21%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, HLTRF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check HUMDF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ELTP has a market cap of 396.6M. Regarding current trading prices, HLTRF is priced at $3.36, while ELTP trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ELTP's P/E ratio is 18.46. In terms of profitability, HLTRF's ROE is -0.21%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, HLTRF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check ELTP's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, VRNOF has a market cap of 358.2M. Regarding current trading prices, HLTRF is priced at $3.36, while VRNOF trades at $0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas VRNOF's P/E ratio is -1.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to VRNOF's ROE of -0.52%. Regarding short-term risk, HLTRF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check VRNOF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CRLBF has a market cap of 337.5M. Regarding current trading prices, HLTRF is priced at $3.36, while CRLBF trades at $0.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CRLBF's P/E ratio is -6.20. In terms of profitability, HLTRF's ROE is -0.21%, compared to CRLBF's ROE of -0.12%. Regarding short-term risk, HLTRF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CRLBF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CPHRF has a market cap of 284.4M. Regarding current trading prices, HLTRF is priced at $3.36, while CPHRF trades at $11.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CPHRF's P/E ratio is 16.73. In terms of profitability, HLTRF's ROE is -0.21%, compared to CPHRF's ROE of +0.16%. Regarding short-term risk, HLTRF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check CPHRF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, HLTRF is priced at $3.36, while BHCCF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HLTRF's ROE is -0.21%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, HLTRF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check BHCCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, HLTRF is priced at $3.36, while PLNHF trades at $0.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HLTRF's ROE is -0.21%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, HLTRF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check PLNHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, HLTRF is priced at $3.36, while PHCUF trades at $7.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas PHCUF's P/E ratio is 700.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, HLTRF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check PHCUF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, HLTRF is priced at $3.36, while SHIEF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, HLTRF's ROE is -0.21%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, HLTRF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check SHIEF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, HLTRF is priced at $3.36, while COPHF trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HLTRF's ROE is -0.21%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HLTRF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check COPHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, LOVFF has a market cap of 127.4M. Regarding current trading prices, HLTRF is priced at $3.36, while LOVFF trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas LOVFF's P/E ratio is 14.78. In terms of profitability, HLTRF's ROE is -0.21%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, HLTRF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check LOVFF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, HLTRF is priced at $3.36, while NWPN trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas NWPN's P/E ratio is -0.04. In terms of profitability, HLTRF's ROE is -0.21%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, HLTRF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check NWPN's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, BIOYF has a market cap of 120.4M. Regarding current trading prices, HLTRF is priced at $3.36, while BIOYF trades at $10.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas BIOYF's P/E ratio is 19.44. In terms of profitability, HLTRF's ROE is -0.21%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, HLTRF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check BIOYF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CBWTF has a market cap of 119.3M. Regarding current trading prices, HLTRF is priced at $3.36, while CBWTF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CBWTF's P/E ratio is 2.95. In terms of profitability, HLTRF's ROE is -0.21%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, HLTRF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CBWTF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, HLTRF is priced at $3.36, while LPCUF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, HLTRF's ROE is -0.21%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, HLTRF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check LPCUF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ORXOF has a market cap of 111.5M. Regarding current trading prices, HLTRF is priced at $3.36, while ORXOF trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ORXOF's P/E ratio is -2.48. In terms of profitability, HLTRF's ROE is -0.21%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, HLTRF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check ORXOF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, HLTRF is priced at $3.36, while CNVCF trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HLTRF's ROE is -0.21%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, HLTRF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check CNVCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ORXOY has a market cap of 102.7M. Regarding current trading prices, HLTRF is priced at $3.36, while ORXOY trades at $2.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ORXOY's P/E ratio is -2.28. In terms of profitability, HLTRF's ROE is -0.21%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, HLTRF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check ORXOY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, AAWH has a market cap of 101.6M. Regarding current trading prices, HLTRF is priced at $3.36, while AAWH trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas AAWH's P/E ratio is -1.19. In terms of profitability, HLTRF's ROE is -0.21%, compared to AAWH's ROE of -2.27%. Regarding short-term risk, HLTRF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check AAWH's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, JUSHF has a market cap of 100.3M. Regarding current trading prices, HLTRF is priced at $3.36, while JUSHF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas JUSHF's P/E ratio is -1.55. In terms of profitability, HLTRF's ROE is -0.21%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, HLTRF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check JUSHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, HLTRF is priced at $3.36, while ABSCF trades at $1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, HLTRF's ROE is -0.21%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, HLTRF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check ABSCF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, CWBHF has a market cap of 95.7M. Regarding current trading prices, HLTRF is priced at $3.36, while CWBHF trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas CWBHF's P/E ratio is -4.29. In terms of profitability, HLTRF's ROE is -0.21%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, HLTRF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check CWBHF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, GRUSF has a market cap of 90.2M. Regarding current trading prices, HLTRF is priced at $3.36, while GRUSF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas GRUSF's P/E ratio is 12.05. In terms of profitability, HLTRF's ROE is -0.21%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, HLTRF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check GRUSF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, HLTRF is priced at $3.36, while EOFBY trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, HLTRF's ROE is -0.21%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, HLTRF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check EOFBY's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, MEDXF has a market cap of 66.7M. Regarding current trading prices, HLTRF is priced at $3.36, while MEDXF trades at $2.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas MEDXF's P/E ratio is -102.90. In terms of profitability, HLTRF's ROE is -0.21%, compared to MEDXF's ROE of -0.00%. Regarding short-term risk, HLTRF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check MEDXF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, HLTRF is priced at $3.36, while GDNSF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, HLTRF's ROE is -0.21%, compared to GDNSF's ROE of -0.24%. Regarding short-term risk, HLTRF is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLTRF.Check GDNSF's competition here

HLTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HLTRF stands at 105.1M. In comparison, PROCF has a market cap of 55.8M. Regarding current trading prices, HLTRF is priced at $3.36, while PROCF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HLTRF currently has a P/E ratio of -7.47, whereas PROCF's P/E ratio is 0.06. In terms of profitability, HLTRF's ROE is -0.21%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, HLTRF is less volatile compared to PROCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTRF.Check PROCF's competition here